We are live on ! Find out more
PRVB

Provention Bio, Inc. Common Stock
PRVB

Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

120 hedge funds and large institutions have $248M invested in Provention Bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 24 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

239% more call options, than puts

Call options by funds: $8.85M | Put options by funds: $2.61M

117% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 24

93% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 15

13% more funds holding

Funds holding: 106 → 120 (+14)

34% less capital invested

Capital invested by funds: $378M → $248M (-$130M)

Holders
120
Holders Change
+14
Holders Change %
+13.21%
% of All Funds
2.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
52
Reduced
24
Closed
15
Calls
$8.85M
Puts
$2.61M
Net Calls
+$6.24M
Net Calls Change
+$7.47M

Top Buyers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
+$10.6M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.59M
3
BlackRock
BlackRock
New York
+$7.57M
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$4.63M
5
Goldman Sachs
Goldman Sachs
New York
+$3.76M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$19.3M
2
DCM
DG Capital Management
New York
-$7.51M
3
MWNA
Marshall Wace North America
New York
-$5.8M
4
Invesco
Invesco
Georgia
-$4.6M
5
6CM
683 Capital Management
New York
-$3.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
101
Bank of Montreal
Ontario, Canada
$22K -$82K -5,827 -72%
PCM
102
Penserra Capital Management
California
$15K +$1.62K +115 +9%
Bank Julius Baer & Co
103
Bank Julius Baer & Co
Switzerland
$13K +$17.6K +1,250 New
TWA
104
TCI Wealth Advisors
Arizona
$12K +$1.41K +100 +10%
TFGT
105
TS Financial Group (TSFG)
Illinois
$10K – – –
WP
106
WealthShield Partners
North Carolina
$10K +$14.1K +1,000 New
IAIM
107
International Assets Investment Management
Florida
$7K +$4.87K +346 +173%
MPWT
108
MassMutual Private Wealth & Trust
Connecticut
$5K – – –
PMFA
109
Plante Moran Financial Advisors
Michigan
$5K – – –
Barclays
110
Barclays
United Kingdom
$3K +$1.73K +123 +63%
BFC
111
Bedel Financial Consulting
Indiana
$3K +$3.53K +251 New
HI
112
Harbour Investments
Wisconsin
$3K +$3.66K +260 New
PCA
113
Providence Capital Advisors
North Carolina
$3K +$3.87K +275 New
WT
114
Whittier Trust
California
$2K +$2.67K +190 New
RFA
115
Reilly Financial Advisors
California
$2K +$2.81K +200 New
Walleye Capital
116
Walleye Capital
New York
$1.09K +$1.46M +103,823 New
Daiwa Securities Group
117
Daiwa Securities Group
Japan
$1K – – –
TF
118
TimeScale Financial
Massachusetts
$1K – – –
CAPTRUST Financial Advisors
119
CAPTRUST Financial Advisors
North Carolina
$1K +$732 +52 New
AIG
120
American International Group
New York
$325 +$45.8K +3,256 +12%
DCM
121
DG Capital Management
New York
– -$7.51M -443,331 Closed
SCM
122
Soleus Capital Management
Connecticut
– -$1.79M -105,941 Closed
Victory Capital Management
123
Victory Capital Management
Texas
– -$1.59M -93,740 Closed
Squarepoint
124
Squarepoint
New York
– -$1.31M -77,301 Closed
Group One Trading
125
Group One Trading
Illinois
– -$756K -53,742 Closed
2 3 4
5
6

PRVB Hedge Fund Activity: Q1 2021 in Review

120 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Provention Bio, Inc. Common Stock (PRVB) for Q1 2021, worth a combined $248M — down 34% from $378M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new PRVB positions and 15 closed out — a net gain of 14 holders — while 52 added to existing stakes and 24 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $10.6M. The largest seller was Perceptive Advisors, cutting an estimated $19.3M.

  • 120 institutional investors held Provention Bio, Inc. Common Stock (PRVB) as of Q1 2021, up from 106 in Q4 2020.
  • Funds reported $248M of Provention Bio, Inc. Common Stock stock for Q1 2021, down 34% quarter-over-quarter.
  • 29 funds opened new Provention Bio, Inc. Common Stock positions in Q1 2021 and 15 closed out, a net change of +14 holders.
  • The largest Provention Bio, Inc. Common Stock buyer in Q1 2021 was Gilder Gagnon Howe & Co, an estimated $10.6M added.
  • The largest Provention Bio, Inc. Common Stock seller in Q1 2021 was Perceptive Advisors, an estimated $19.3M sold.

Based on aggregated 13F filings for Q1 2021.